Muscat: Khazaen Economic City signed here today an agreement with Opal for biopharmaceuticals and business company to establish a factory for the production of biological human vaccines to the tune of OMR 20 million.
The first phase of the project will be set up on a total area of 37,000 square meters.
The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal for biopharmaceuticals and business company.
Al Thuhli said that the project will be the first vaccines factory in Khazaen Economic City and it targets local and International markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
more recommended stories
-
HONGQI Makes its Electric Vehicle Debut at the Paris Motor Show 2024
Muscat: HONGQI, celebrated as the “World’s New.
-
His Majesty Congratulates New Ethiobian President
Muscat: His Majesty Sultan Haitham bin.
-
Hafeet Rail Signs Financing Agreements Worth RO 577mn
Hafeet Rail Signs Bank Financing Agreements.
-
Bank Nizwa Showcases Innovative Sharia-Compliant Financial Solutions at SQU Mazaya Exhibition
Muscat: Committed to fostering awareness of.
-
ahli islamic wins Excellence in Retail Islamic Banking award 2024
Muscat: ahli islamic’s outstanding performance gained.
-
Nakheel Oman announces date for purchasing Busoor for 2024 season
Muscat: Oman Palm Development Company, in.
-
Oman Oil Price Drops 1.46 US Dollars
Muscat: Oman oil price (December delivery.
-
Voltamp Energy reveals developments in lawsuit against Credit Oman
Disclosure of the court session in.
-
Oman delegation holds meetings in Finland and Estonia
Muscat: H.E. Qais bin Mohammed Al.
-
Oman LNG signs 4-year contract with Kansai Electric Power
Muscat: Oman LNG signed a 4-year.